144 related articles for article (PubMed ID: 35264465)
1. Urushiol V Suppresses Cell Proliferation and Enhances Antitumor Activity of 5-FU in Human Colon Cancer Cells by Downregulating FoxM1.
Jeong JH; Ryu JH
Biomol Ther (Seoul); 2022 May; 30(3):257-264. PubMed ID: 35264465
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression.
Varghese V; Magnani L; Harada-Shoji N; Mauri F; Szydlo RM; Yao S; Lam EW; Kenny LM
Sci Rep; 2019 Feb; 9(1):1505. PubMed ID: 30728402
[TBL] [Abstract][Full Text] [Related]
5. Circ-PRKDC Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells by Regulating miR-375/FOXM1 Axis and Wnt/β-Catenin Pathway.
Chen H; Pei L; Xie P; Guo G
Onco Targets Ther; 2020; 13():5939-5953. PubMed ID: 32606803
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin Analog [V
Sobol NT; Solerno LM; Llavona C; Alonso DF; Garona J
World J Oncol; 2023 Dec; 14(6):540-550. PubMed ID: 38022396
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
[TBL] [Abstract][Full Text] [Related]
8. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of the efficacy and potential genotoxic hazard of combined SAHA and 5-FU treatment in the chemoresistant colorectal cancer cell lines.
Bálintová L; Matúšková M; Gábelová A
Mutat Res Genet Toxicol Environ Mutagen; 2022; 874-875():503445. PubMed ID: 35151424
[TBL] [Abstract][Full Text] [Related]
11. miR-361 enhances sensitivity to 5-fluorouracil by targeting the FOXM1-ABCC5/10 signaling pathway in colorectal cancer.
Zhang L; Li B; Zhang B; Zhang H; Suo J
Oncol Lett; 2019 Oct; 18(4):4064-4073. PubMed ID: 31579069
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of TMEM45A overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal cancer cells through inhibition of TGF-β signalling pathway.
Zhu M; Jiang B; Yan D; Wang X; Ge H; Sun Y
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):503-516. PubMed ID: 31788833
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
[TBL] [Abstract][Full Text] [Related]
14. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase.
Klinhom-On N; Seubwai W; Sawanyawisuth K; Obchoei S; Mahalapbutr P; Wongkham S
Life Sci; 2021 Dec; 286():120072. PubMed ID: 34688691
[TBL] [Abstract][Full Text] [Related]
16. Acriflavine enhances the antitumor activity of the chemotherapeutic drug 5-fluorouracil in colorectal cancer cells.
Zargar P; Ghani E; Mashayekhi FJ; Ramezani A; Eftekhar E
Oncol Lett; 2018 Jun; 15(6):10084-10090. PubMed ID: 29928378
[TBL] [Abstract][Full Text] [Related]
17. Emodin reverses 5-Fu resistance in human colorectal cancer via downregulation of PI3K/Akt signaling pathway.
Li T; Si W; Zhu J; Yin L; Zhong C
Am J Transl Res; 2020; 12(5):1851-1861. PubMed ID: 32509181
[TBL] [Abstract][Full Text] [Related]
18. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
Lee JH; Lee SW
Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
[TBL] [Abstract][Full Text] [Related]
20. Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells.
Hu L; Liang Y; Wu K; Wang C; Zhang T; Peng R; Zou F
Ann Transl Med; 2021 Jan; 9(2):114. PubMed ID: 33569416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
